Webinar: Regulatory Strategy in the EAEU and Rest of CIS Countries
Regulatory strategy in EAEU and CIS regions differ from other regions as market access to these countries can be a real challenge due to various local regulations. However, it is only a matter of experience and adequate know-how.
This webinar focuses on choosing your regulatory strategy for Eurasian Economic Union and Commonwealth of Independent States, best practices and practical tips for market access and current regulatory status and GMP requirements.
You will learn about:
1. Commonwealth of Independent States
- Differences and overlaps with EAEU
2. Regulatory strategy in the EAEU
- Current status and main challenges
- Practical tips
3. Regulatory strategy in the CIS region
- What is the current status?
- Best practices and key tips for main challenges
- GMP requirements in EAEU and CIS
Entering EAEU or CIS markets?
Make use of our experts’ know-how to access new markets. Explore your options in a chat with one of our experts.
Who should attend?
- Global and regional RA Managers
- Regulatory Strategy Managers
- RA Partnerships Operations Manager
- QA Managers supporting RA
- RA Healthcare Compliance Managers
Duration: 25 min.
Speaker: Regulatory Affairs Project Manager, Nargiz Asgarova, who will share her expertise on regulatory strategy in EAEU and CIS regions.
Nargiz Asgarova, BSc, MBA
Regulatory Affairs Project Manager
Other content that might interest you:
eCTD implementation across MENA region: What is the current status?
As the electronic Common Technical Document (eCTD) became the standard for submitting Regulatory Information to leading agencies worldwide, its adoption still poses a considerable challenge for those agencies who lack the needed human and/or material resources. How is...
Building Health Literacy: The Value of Good Writing
Scientists, doctors, and health authorities often use written communication to present their research, opinions, or guidelines to the patients. While the questions they approach may be complex, the language should not. In medical documents, misinterpreted information may endanger the health and life of a patient. Thus, the main goal in medical writing is to convey the message clearly and concisely to avoid misinterpretation.
CMC: Down the road in effective IND/IMPD writing
In the previous two articles, we have shared our experience on various aspects of effective IND/IMPD CMC writing, considering proper planning, assigning a dedicated CMC writing team, and having effective project management. In addition, we discussed technical writing particulars giving some key messages on document preparation. Now, we will discuss other important points. These are safety, data completeness, and geographical regions.
